药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
8-azaguanine
The risk or severity of adverse effects can be increased when 8-azaguanine is combined with Indacaterol.
Trilostane
Fenethylline
The risk or severity of adverse effects can be increased when Fenethylline is combined with Indacaterol.
Trilostane
Theobromine
The risk or severity of adverse effects can be increased when Theobromine is combined with Indacaterol.
Trilostane
Aminophylline
The risk or severity of adverse effects can be increased when Aminophylline is combined with Indacaterol.
Trilostane
Naxitamab
The risk or severity of hypertension can be increased when Indacaterol is combined with Naxitamab.
Trilostane
Loxoprofen
The risk or severity of hypertension can be increased when Indacaterol is combined with Loxoprofen.
Trilostane
Selpercatinib
The risk or severity of hypertension can be increased when Indacaterol is combined with Selpercatinib.
Trilostane
Diethyl ether
The risk or severity of hypertension can be increased when Indacaterol is combined with Diethyl ether.
Trilostane
Zomepirac
The risk or severity of hypertension can be increased when Zomepirac is combined with Indacaterol.
Trilostane
Yohimbine
The risk or severity of hypertension can be increased when Yohimbine is combined with Indacaterol.
Trilostane
Siponimod
The risk or severity of hypertension can be increased when Indacaterol is combined with Siponimod.
Trilostane
Propacetamol
The risk or severity of hypertension can be increased when Indacaterol is combined with Propacetamol.
Trilostane
Tolfenamic acid
The risk or severity of hypertension can be increased when Indacaterol is combined with Tolfenamic acid.
Trilostane
Vortioxetine
The risk or severity of hypertension can be increased when Indacaterol is combined with Vortioxetine.
Trilostane
Cannabidiol
The risk or severity of hypertension can be increased when Indacaterol is combined with Cannabidiol.
Trilostane
Parecoxib
The risk or severity of hypertension can be increased when Indacaterol is combined with Parecoxib.
Trilostane
Vilazodone
The risk or severity of hypertension can be increased when Indacaterol is combined with Vilazodone.
Trilostane
Safinamide
The risk or severity of hypertension can be increased when Indacaterol is combined with Safinamide.
Trilostane
Nylidrin
The risk or severity of hypertension can be increased when Indacaterol is combined with Nylidrin.
Trilostane
Mianserin
The risk or severity of hypertension can be increased when Indacaterol is combined with Mianserin.